Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Rinvoq (upadacitinib)
Pharma
AbbVie's Rinvoq passes midstage test in SLE
AbbVie's Rinvoq has been picking up FDA approvals left and right in recent years. Now it's showing its worth in systemic lupus erythematosus.
Eric Sagonowsky
May 31, 2023 10:16am
Intra-Cellular winner of the Fierce Madness Drug Ad Tournament
Mar 22, 2023 8:30am
AbbVie's immunology stalwart Skyrizi clinches a 3rd indication
Jun 17, 2022 11:01am
Dupixent leads TV ad spending for 2nd month in a row
Jun 8, 2022 10:00am
Dupixent retakes TV ad spending crown from AbbVie's Rinvoq
May 6, 2022 12:31pm
Docs turning to Bristol's aging Orencia amid JAK safety woes
Apr 13, 2022 9:30am
